Author

Alicia D. Nicklin

Norwich Research Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Christopher A. PriceiD· 3 shared Lindsay J. HalliD· 3 shared Luke J MitchelliD· 3 shared Nilda Ilker· 3 shared Stephen David RobinsoniD· 3 shared Alastair M. McKeeiD· 2 shared Mitchel Rowe· 2 shared Régis StentziD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Christopher A. PriceORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyMicrobiology SpectrumPeer-reviewedSep 29, 2026

Systemically delivered Bacteroides thetaiotaomicron-derived bacterial extracellular vesicles inhibit primary and metastatic melanoma growth

Christopher A. Price, Emily J. Jones, Nilda Ilker…·Stephen David Robinson

This study shows that Bacteroides thetaiotaomicron-derived extracellular vesicles inhibit melanoma growth via immune activation rather than direct cytotoxicity.

DOI 10.1128/spectrum.02512-26

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 8, 2026

Bifidobacterium pseudocatenulatum extracellular vesicles promote Ly6G+ granulocyte infiltration to inhibit melanoma tumour progression

Alicia D. Nicklin, Anne Jordan, Christopher A. Price…·Stephen David Robinson

This paper shows that Bifidobacterium pseudocatenulatum extracellular vesicles reduce melanoma growth by promoting Ly6G+ granulocyte infiltration through TLR2 activation.

DOI 10.64898/2026.06.08.731027

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 23, 2024

Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer

Christopher A. Price, Alicia D. Nicklin, Magdalena Kujawska…·Stephen David Robinson

This study shows that Bifidobacterium pseudocatenulatum 210 EPS enhances anti-tumour immunity and improves cancer therapy responses in pre-clinical models.

1 citation

mousemetagenomics

𝕏 PostBluesky